DISCOUNT-ZERTIFIKAT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 10:47:08 31/05/2024 BST | ||
| 37.17 EUR | -.--% |
|
| 1 month | -9.32% | ||
| 3 months | -12.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 37.17 | -.--% |
| 30/05/24 | 37.17 | -0.51% |
| 29/05/24 | 37.36 | +0.62% |
| 28/05/24 | 37.13 | -2.75% |
| 27/05/24 | 38.18 | +0.79% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 10:47 am
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC8REA |
| ISIN | DE000HC8REA7 |
| Date issued | 16/08/2023 |
| Maturity | 21/06/2024 (19 Days) |
| Parity | 1 : 1 |
| Emission price | 41.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 43.77 € |
|---|---|
| Lowest since issue | 36.9 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat